SM-8849

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameSM-8849
Drug Alias NameSM-8849
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCD44 antigen inhibitors
TargetsCD44 antigen
Therapy Area/IndicationsEncopresisUrinary IncontinenceFecal Incontinence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaSweden +[10] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorgine
Active IndicationsN/A
Inactive IndicationsEncopresisUrinary IncontinenceFecal Incontinence

Other Information

ATC CodeN/A
Related LinksN/A